Back to full study details
Washington Dc, DCNow Enrolling

Melanoma Clinical Trial in Washington Dc, DC

Access cutting-edge melanoma treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Expert Care

Access melanoma specialists in Washington Dc at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related melanoma treatment provided free

About This Melanoma Study in Washington Dc

The purpose of this study is to test the effects of anti-PI-1 inhibitor (TSR-042) or anti-PD-1/anti-TIM-3 combination (TSR-042 / TSR-022) in patients with operable melanoma.

Sponsor: Diwakar Davar

Apply for This Washington Dc Location

Check if you qualify for this melanoma clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Melanoma Treatment Options in Washington Dc, DC

If you're searching for melanoma treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Why Consider a Clinical Trial for Melanoma?

  • Access to new treatments before they're widely available
  • Receive care from leading melanoma specialists in Washington Dc
  • Contribute to medical research that could help future patients
  • Study-related care is typically provided at no cost
  • Close monitoring by a dedicated research team
  • Possible compensation for time and travel